Molecular identification of clinical “difficult-to-identify” microbes from sequencing 16S ribosomal DNA and internal transcribed spacer 2

Abstract

BackgroundClinical microbiology laboratories have to accurately identify clinical microbes. However, some isolates are difficult to identify by the automated biochemical text platforms, which are called “difficult-to-identify” microbes in this study. Therefore, the ability of 16S ribosomal DNA (16S rDNA) and internal transcribed spacer 2 (ITS2) sequencing to identify these “difficult-to-identify” bacteria and fungi was assessed in this study.MethodsSamples obtained from a teaching hospital over the past three years were examined. The 16S rDNA of four standard strains, 18 clinical common isolates, and 47 “difficult-to-identify” clinical bacteria were amplified by PCR and sequenced. The ITS2 of eight standard strains and 31 “difficult-to-identify” clinical fungi were also amplified by PCR and sequenced. The sequences of 16S rDNA and ITS2 were compared to reference data available in GenBank by using the BLASTN program. These microbes were identified according to the percentage of similarity to reference sequences of strains in GenBank.ResultsThe results from molecular sequencing methods correlated well with automated microbiological identification systems for common clinical isolates. Sequencing results of the standard strains were consistent with their known phenotype. Overall, 47 “difficult-to-identify” clinical bacteria were identified as 35 genera or species by sequence analysis (with 10 of these identified isolates first reported in clinical specimens in China and two first identified in the international literature). 31 “difficult-to-identify” clinical fungi tested could be identified as 15 genera or species by sequence analysis (with two of these first reported in China).ConclusionsOur results show the importance of 16S rDNA and internal ITS2 sequencing for the molecular identification of “difficult-to-identify” bacteria and fungi. The development of this method with advantages of convenience, availability, and cost-effectiveness will make it worth extending into clinical practice in developing countries.

Prevalence and antimicrobial susceptibility pattern of Salmonella and Shigella species among asymptomatic food handlers working in Haramaya University cafeterias, Eastern Ethiopia

“…On the other hand, the MDR Shigella spp. is also low compared to studies conducted in other parts of Ethiopia such as Addis Ababa University (100%) [21] and Arba Minch University (100%) [14]. The cause of variations in the prevalence of MDR is unknown, but might be due to inappropriate empirical antimicrobial treatment, easy availability and indiscriminate use of common antimicrobials.…”

“…(Pink–red with a black center colonies) and Shigella spp. (Pink-red colonies) [13, 14]. Culture positives were characterized by standard biochemical tests, including motility (CM0435B, Oxoid, Ltd, UK), indole test (CM0967B, Oxoid, Ltd, UK), and Kligler iron agar reactions (CM0033B, Oxoid, Ltd, UK).…”

Mortality markers in nosocomial Klebsiella pneumoniae bloodstream infection

“…In a study investigated instrument-related infections developing during 2003–2012 in our country and including all ICUs of 29 hospitals from 10 cities CRKp resistance rate at CLABSI was 6.3% (Leblebicioglu et al 2014). In two separate studies investigating HAI developing in ICUs during 2009–2011 and 2012 CRKp rate was 22 and 48% respectively (Ulu et al 2015; Budak et al 2014).…”

Brachybacterium paraconglomeratum Endophthalmitis Postcataract Operation

“…was first proposed by Tamai et al in 2018, but there are only a few reports of Brachybacterium spp. isolated from human samples [1,[6][7][8]. It is not known why human infections by Brachybacterium spp.…”